• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Biden-Harris administration using taxpayer money to mask Medicare premium hikes before election: critics

by August 14, 2024
written by August 14, 2024

In a move critics say is designed to shield the Biden-Harris administration from election fallout, the administration has leveraged taxpayer funds to mask upcoming increases in Medicare premiums.

Under the Inflation Reduction Act (IRA), which was intended to cap out-of-pocket drug costs for Medicare beneficiaries, insurers are poised to significantly hike monthly premiums, with average bids for Part D plans expected to triple by 2025.

In response to potential voter backlash, the Centers for Medicare and Medicaid Services (CMS) rolled out a three-year ‘demonstration project’ to subsidize these premiums, aiming to keep them artificially low. However, despite the appearance of relief, some critics are saying that taxpayers will fund a dramatic increase in subsidies — from $30 per recipient per month in 2024 to $142.70 in 2025 — raising concerns about the long-term impact on government spending and debt. 

Former President Trump advisor Joe Grogan has criticized the maneuver, arguing that it merely shifts costs rather than providing real relief.

‘They’ve destroyed part D premiums,’ Grogan told Fox News Digital in an interview. ‘I’m not sure it’ll survive legal scrutiny if someone were to sue. Objectively, it shouldn’t be done. It’s just interjecting $5-10 billion of taxpayer dollars, while the taxpayers are paying the price 85 days before an election. It’s sickening.’

‘This is only going to get worse in 2025, 2026,’ Grogan continued. ‘The program is in a death spiral. They announced a three-year demo. It’s already broken. The demo is going to fail. Premiums are still going to go up.’

Paragon Health Institute, a health care research group, called the CMS demo plan a ‘fake, costly demonstration,’ in a recent analysis. 

‘Fearing the premium increases that the IRA redesign will impose on Part D plans, CMS has now launched a new voluntary, nationwide demonstration program that is neither a demonstration nor voluntary. Unlike this massive subsidization scheme, demonstrations are supposed to be limited in nature and test alternative features of program design,’ the institute wrote. ‘As a result of the IRA changes, insurers that don’t participate are expected to either be uncompetitive from a price perspective or face significant losses – hardly a choice for insurers.’

Research published by Fidelity, an investment research group, shows that a 65-year-old retiring today can expect to spend $165,000 on health care in retirement, a 5% increase from last year and more than double the estimate from 2002.

Yet, there appears to be a disconnect for many Americans between the actual projected cost of health care in retirement and how much they expect to spend on those expenses. The average American thinks they will spend about $75,000 on health care and other medical expenses, less than half of Fidelity’s calculation, according to the research.

The estimate assumes that an individual is enrolled in Medicare – including Part A and Part B, which cover most hospital care and doctor’s visits – and Part D, which covers prescription drugs. Other expenses such as Medicare premiums, over-the-counter medications, dental and vision care and other costs typically not covered by Medicare are ‘left to retirees to manage on their own,’ the report said.

As of April 2024, about 67.3 million Americans were enrolled in Medicare, according to the Centers for Medicare and Medicaid Services. Of those, about half were enrolled in a Medicare Advantage plan, while about 80% were covered by Medicare Part D.

‘They just want to get through the election,’ Grogan said. ‘They’re hoping after the election they can face it, but its gonna need to be dealt with in the next 12–18 months. They did not believe it would be this bad and its only gonna get worse.’ 

Americans are also dealing with a spike in the cost of prescription drugs, which has surged nearly 40% over the past decade, easily outstripping the pace of inflation. 

Fox News Digital has reached out to CMS for comment. 

Fox Business’ Megan Henney contributed to this report. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Oil and natural gas: oil price in retreat since Tuesday
next post
The dollar index under strong bearish pressure this week

related articles

Elon Musk sports black eye at farewell presser...

May 30, 2025

Biden says he could ‘beat the hell out...

May 30, 2025

Donald Trump fires National Portrait Gallery director for...

May 30, 2025

‘American hero’ or ‘failure’: Elon Musk’s DOGE departure...

May 30, 2025

Unfinished Business: The budget cuts Musk couldn’t complete...

May 30, 2025

Alleged attempt to impersonate White House chief of...

May 30, 2025

Inside the late-night drama that led to Trump’s...

May 30, 2025

I’m a physician and I’m worried that our...

May 30, 2025

Trump denounces court’s ‘political’ tariff decision, calls on...

May 30, 2025

President Trump teases ‘last day, but not really’...

May 30, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Obama urges Americans to ‘possibly sacrifice’ in resisting Trump policies

    April 4, 2025
  • The big tech sell-off: are the ‘Magnificent 7’ stocks overvalued or oversold?

    March 19, 2025
  • Survivor of Nova music festival Hamas terror attack wins slot to represent Israel at Eurovision

    January 23, 2025
  • Ripple and Tron: Ripple is back at the weekly open price

    August 1, 2024
  • Israeli PM Benjamin Netanyahu completes prostate surgery after UTI diagnosis

    December 30, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (4,731)
  • Investing (624)
  • Stock (775)

Latest Posts

  • Bitcoin and Ethereum: New Support and Targets for Friday

    October 4, 2024
  • Trump has Christmas message to ‘Radical Left Lunatics,’ tells inmates Biden granted clemency to ‘GO TO HELL!’

    December 26, 2024
  • Trump teases running for a third term: ‘Not joking’

    March 30, 2025

Recent Posts

  • EURGBP and EURCHF: EURGBP is recovering successfully

    September 5, 2024
  • Is Iran’s new president presenting a moderating image to lure the West back into a nuclear deal?

    September 29, 2024
  • Gold and Silver: Gold in a new rush to last week’s high

    August 26, 2024

Editor’s Pick

  • These are the top names in contention for Defense secretary under Trump

    November 12, 2024
  • Short CRSP: Stock Forms Head and Shoulders Pattern, Eyeing short term Neckline Retest

    July 12, 2024
  • Encircling Taiwan was a smokescreen for China’s real goal of convincing US not to intervene, expert says

    October 20, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock